MM

Matthew Mcaviney

Partner at New Enterprise Associates (NEA)

San Francisco, California

Overview 

Matthew McAviney is a Partner at New Enterprise Associates (NEA) in San Francisco, California, with a background in financial modeling, biotechnology, and venture capital. He has made significant investments in companies like AviadoBio and Sagimet Biosciences, focusing on sectors such as Pharmaceuticals and BioTech. McAviney holds an MBA from The University of Chicago Booth School of Business and an MD from the University of Illinois College of Medicine, bringing a unique blend of medical and business expertise to his role as a Partner at NEA.

Work Experience 

NE

New Enterprise Associates (NEA)

  • Partner

    2018 - Current

    Biopharma

New Enterprise Associates is a venture capital firm that focuses on investments in technology and healthcare startups.

nea.com
FC

F-Prime Capital

  • Principal

    2013 - 2018

    Biopharma Portfolio companies: Apellis, Avalyn, Denali, Iora, Modis, Semma, Surface, Unum

F-Prime Capital is a venture capital firm investing in healthcare and technology.

fprimecapital.com
OW

Oliver Wyman

  • Associate, Health & Life Sciences Practice

    2012 - 2013

    Healthcare strategy and due diligence engagements

CAVOK is a technical consulting firm that supports the development of manual systems and processes.

cavokgroup.com
RW

Robert W. Baird & Co.

  • Senior Equity Research Associate, Biotechnology

    2011 - 2012

    Senior Analyst: Chris Raymond Sample coverage list: Amgen, Biogen, Celgene, Alexion, Regeneron, Biomarin, Onyx, Tesaro, Human Genome Sciences, Amag, Dendreon, Endocyte, New Link Genetics

Baird is a financial company that provides wealth management, capital markets, private equity, and asset management services.

bairdcareers.com

Education 

Investments 

AviadoBio

Series A

Total funding: $78M

Sagimet Biosciences

Series Unknown

Total funding: $190M

Articles About Matthew

Relevant Websites